222 related articles for article (PubMed ID: 35962406)
21. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.
Marsh JCW; Risitano AM; Mufti GJ
Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354
[TBL] [Abstract][Full Text] [Related]
22. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
23. Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
Peffault de Latour R; Huynh L; Ivanova JI; Totev T; Bilginsoy M; Antin J; Roy A; Duh MS
Ann Hematol; 2020 Apr; 99(4):743-752. PubMed ID: 32065291
[TBL] [Abstract][Full Text] [Related]
24. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy.
Cheng Y; Xu Z; Zhang Y; Wu J; Wang F; Mo X; Chen Y; Han W; Jia J; Wang Y; Zhang X; Huang X; Zhang L; Xu L
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29297952
[TBL] [Abstract][Full Text] [Related]
25. Aplastic anemia: therapeutic updates in immunosuppression and transplantation.
Scheinberg P
Hematology Am Soc Hematol Educ Program; 2012; 2012():292-300. PubMed ID: 23233595
[TBL] [Abstract][Full Text] [Related]
26. Management of acquired aplastic anemia in children : A single center experience.
Yazal Erdem A; Arman Bilir Ö; Işık M; Kaçar D; Özbek NY; Yaralı HN
Transfus Apher Sci; 2019 Aug; 58(4):484-490. PubMed ID: 31151809
[TBL] [Abstract][Full Text] [Related]
27. Partial SAA patients benefit from delayed response of IST.
Wang T; Wang C; Liu C; Shao Z; Fu R
Front Immunol; 2023; 14():1067977. PubMed ID: 36845107
[TBL] [Abstract][Full Text] [Related]
28. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Patel BA; Groarke EM; Lotter J; Shalhoub R; Gutierrez-Rodrigues F; Rios O; Quinones Raffo D; Wu CO; Young NS
Blood; 2022 Jan; 139(1):34-43. PubMed ID: 34525188
[TBL] [Abstract][Full Text] [Related]
30. Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
Hwang YY; Chan TSY; Chan FHY; Lau CWP; Luk YY; Lau GWN; Chan KP; Leung KH; Kho B; Lau JSM; Lau CK; Mak V; Yip SF; Lin SY; Sim JPY; Kwong YL
Ann Hematol; 2022 Jun; 101(6):1163-1172. PubMed ID: 35412083
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia.
Zhao Y; Yang W; Zhao X; Hu X; Hu J; Liu X; Li J; Ye L; Xiong Y; Yang Y; Zhang B; Li X; Yang X; Shi Y; Peng G; Li Y; Fan H; Zhou K; Jing L; Zhang L; Zhang F
Front Pediatr; 2022; 10():1095143. PubMed ID: 36704148
[TBL] [Abstract][Full Text] [Related]
32. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
[TBL] [Abstract][Full Text] [Related]
33. Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.
Alotaibi H; Aljurf M; de Latour R; Alfayez M; Bacigalupo A; Fakih RE; Schrezenmeier H; Ahmed SO; Gluckman E; Iqbal S; Höchsmann B; Halkes C; de la Fuente J; Alshehry N; Cesaro S; Passweg J; Dufour C; Risitano AM; DiPersio J; Motabi I
Transplant Cell Ther; 2022 Feb; 28(2):105.e1-105.e7. PubMed ID: 34649020
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Eltrombopag with Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone on Severe Aplastic Anaemia: A Systematic Review and Meta-analysis.
Zhang S; Wang Q; Cui K; Cheng B; Fan J; Hu S
Clin Drug Investig; 2023 May; 43(5):315-324. PubMed ID: 37165250
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy and safety analysis of eltrombopag and recombinant human thrombopoietin combined with immunosuppressive therapy for severe aplastic anemia].
Yuan FF; Zhang QL; Zhang LN; Xiong YY; Li MJ; Zhou H; Wei XD; Liu XJ; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1021-1024. PubMed ID: 35045674
[No Abstract] [Full Text] [Related]
36. Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.
Wu LQ; Huang LF; Yang H; Ye BD; Sheng JP; Yu QH; Yang Y; Jia JS; Zhang DH; Lin SY; He GS; Li JY
Ann Hematol; 2023 Aug; 102(8):2015-2023. PubMed ID: 37193759
[TBL] [Abstract][Full Text] [Related]
37. Current insights into the treatments of severe aplastic anemia in China.
Ye L; Zhang F; Kojima S
Int J Hematol; 2020 Sep; 112(3):292-299. PubMed ID: 32748215
[TBL] [Abstract][Full Text] [Related]
38. Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world.
Li R; Wang N; Chai X; Yang L; Liu K; He H; Lin S; Yang Y; Jia J; Zhang D; Gong Y; Shi J; He G; Li J
Clin Exp Med; 2023 Oct; 23(6):2619-2627. PubMed ID: 36645546
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
Choi YB; Yi ES; Lee JW; Sung KW; Koo HH; Yoo KH
Bone Marrow Transplant; 2017 Jan; 52(1):47-52. PubMed ID: 27668766
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
